Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.2% in First Three Quarters of 2022

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 94.7 million yuan in the first three quarters of 2022, up 4.2% year-on-year.

Meanwhile, the company posted 4.1 billion yuan in revenue, up 13.4% year-on-year.

At the end of the reporting period, it had 8.4 billion yuan in total assets and 5 billion yuan in total liabilities, with a liability-to-asset ratio of 58.8%.